We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.52%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$287B
AUM Growth
+$18.5B
(+6.9%)
Cap. Flow
-$4.92B
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
26.06%
Holding
3,383
New
280
Increased
1,384
Reduced
1,249
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$672M |
| 2 |
Applied Materials
AMAT
|
+$241M |
| 3 |
Kenvue
KVUE
|
+$220M |
| 4 |
Salesforce
CRM
|
+$210M |
| 5 |
PayPal
PYPL
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.25B |
| 2 |
Advanced Micro Devices
AMD
|
+$526M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$443M |
| 4 |
Chubb
CB
|
+$335M |
| 5 |
Microsoft
MSFT
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.88% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
SandRidge Energy
SD
$503M
| $1.22M | ﹤0.01% |
80,292
-76,578
| -49% | -$1.12M |
|
2527
SGHC Ltd
SGHC
$6.63B
| $1.22M | ﹤0.01% |
+421,457
| New | +$1.49M |
|
|
ACRE
2528
Ares Commercial Real Estate
ACRE
$270M
| $1.22M | ﹤0.01% |
120,301
| – | – |
|
2529
QuinStreet
QNST
$1.21B
| $1.22M | ﹤0.01% |
137,654
+6,908
| +5% | +$69.7K |
|
2530
Sight Sciences
SGHT
$412M
| $1.21M | ﹤0.01% |
146,549
+18,020
| +14% | +$162K |
|
2531
Liberty Latin America Class A
LILA
$1.67B
| $1.21M | ﹤0.01% |
+203,868
| New | +$1.14M |
|
2532
Biomea Fusion
BMEA
$91.3M
| $1.21M | ﹤0.01% |
+55,075
| New | +$1.72M |
|
|
NOTE
2533
DELISTED
FiscalNote
NOTE
| $1.21M | ﹤0.01% |
+27,637
| New | +$776K |
|
2534
Lindblad Expeditions
LIND
$2.22B
| $1.2M | ﹤0.01% |
110,712
-2,677
| -2% | -$27.5K |
|
2535
PMV Pharmaceuticals
PMVP
$63.5M
| $1.2M | ﹤0.01% |
192,384
+104,287
| +118% | +$546K |
|
|
DSKE
2536
DELISTED
Daseke, Inc. Common Stock
DSKE
| $1.2M | ﹤0.01% |
168,476
-231,453
| -58% | -$1.63M |
|
|
SWI
2537
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.2M | ﹤0.01% |
117,005
| – | – |
|
2538
Enanta Pharmaceuticals
ENTA
$400M
| $1.2M | ﹤0.01% |
56,096
| – | – |
|
2539
Liquidia Corp
LQDA
$8.02B
| $1.2M | ﹤0.01% |
152,808
| – | – |
|
2540
Lufax Holding
LU
$1.3B
| $1.2M | ﹤0.01% |
209,485
-40,475
| -16% | -$268K |
|
|
TBRG
2541
DELISTED
TruBridge
TBRG
| $1.2M | ﹤0.01% |
48,426
-44,606
| -48% | -$1.16M |
|
|
CFB
2542
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.2M | ﹤0.01% |
119,548
+25,047
| +27% | +$258K |
|
2543
Merchants Bancorp
MBIN
$2.49B
| $1.2M | ﹤0.01% |
46,730
-19,754
| -30% | -$489K |
|
2544
Coherus Oncology
CHRS
$196M
| $1.19M | ﹤0.01% |
279,826
+104,167
| +59% | +$615K |
|
2545
ImmunityBio
IBRX
$8.1B
| $1.19M | ﹤0.01% |
429,725
+189,140
| +79% | +$535K |
|
|
ORGN
2546
DELISTED
Origin Materials
ORGN
| $1.19M | ﹤0.01% |
9,346
| – | – |
|
2547
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $1.19M | ﹤0.01% |
29,132
+2,493
| +9% | +$96.4K |
|
2548
Edgewise Therapeutics
EWTX
$4.73B
| $1.19M | ﹤0.01% |
153,502
+55,678
| +57% | +$470K |
|
2549
Alignment Healthcare
ALHC
$2.98B
| $1.19M | ﹤0.01% |
206,187
-12,661
| -6% | -$81.9K |
|
2550
FRP Holdings
FRPH
$421M
| $1.18M | ﹤0.01% |
40,892
| – | – |
|
Similar funds
VFT
Nuveen's Q2 2023 Portfolio in Review
As of Q2 2023, Nuveen held 3,383 positions worth $287B, up 6.9% from $269B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Nuveen's Q2 2023 filing shows 280 new, 1,384 increased, 1,249 reduced and 179 closed positions. Its largest new stake was Kenvue: 8,445,273 shares worth $223M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2023 buy was Kenvue: 8,445,273 shares worth $223M.
- Nuveen added most to Amazon in Q2 2023, an estimated $672M increase.
- Nuveen's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.25B.
- Nuveen fully exited Qualtrics International Inc. Class A Common Stock in Q2 2023, selling an estimated $130M.
- Nuveen's ten largest holdings make up 26% of its $287B portfolio in Q2 2023.
- Nuveen opened 280 new positions and closed 179 in Q2 2023.
- Nuveen's portfolio value rose 6.9% quarter-over-quarter to $287B.
Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.